156 related articles for article (PubMed ID: 11960488)
1. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
[TBL] [Abstract][Full Text] [Related]
3. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II.
Lindman S; Lindeberg G; Gogoll A; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2001 Mar; 9(3):763-72. PubMed ID: 11310611
[TBL] [Abstract][Full Text] [Related]
5. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Synnergren B; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1999 Nov; 42(22):4524-37. PubMed ID: 10579816
[TBL] [Abstract][Full Text] [Related]
7. Bicyclic tripeptide mimetics with reverse turn inducing properties.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
J Med Chem; 1999 Feb; 42(4):601-8. PubMed ID: 10052967
[TBL] [Abstract][Full Text] [Related]
8. The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.
Matsoukas JM; Polevaya L; Ancans J; Mavromoustakos T; Kolocouris A; Roumelioti P; Vlahakos DV; Yamdagni R; Wu Q; Moore GJ
Bioorg Med Chem; 2000 Jan; 8(1):1-10. PubMed ID: 10968258
[TBL] [Abstract][Full Text] [Related]
9. The utility of side-chain cyclization in determining the receptor-bound conformation of peptides: cyclic tripeptides and angiotensin II.
Kataoka T; Beusen DD; Clark JD; Yodo M; Marshall GR
Biopolymers; 1992 Nov; 32(11):1519-33. PubMed ID: 1333831
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation.
Le MT; Vanderheyden PM; Szaszák M; Hunyady L; Vauquelin G
J Biol Chem; 2002 Jun; 277(26):23107-10. PubMed ID: 12006574
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists.
Polevaya L; Mavromoustakos T; Zoumboulakis P; Golic Grdadolnik S; Roumelioti P; Giatas N; Mutule I; Keivish T; Vlahakos DV; Iliodromitis EK; Kremastinos DT; Matsoukas J
Bioorg Med Chem; 2001 Jun; 9(6):1639-47. PubMed ID: 11408184
[TBL] [Abstract][Full Text] [Related]
13. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II.
Lindman S; Lindeberg G; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2000 Sep; 8(9):2375-83. PubMed ID: 11026551
[TBL] [Abstract][Full Text] [Related]
15. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
Moore GJ; Ganter RC; Goghari MH; Franklin KJ
Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
[TBL] [Abstract][Full Text] [Related]
16. A frame shifted disulfide bridged analogue of angiotensin II.
Schmidt B; Kühn C; Ehlert DK; Lindeberg G; Lindman S; Karlén A; Hallberg A
Bioorg Med Chem; 2003 Mar; 11(6):985-90. PubMed ID: 12614883
[TBL] [Abstract][Full Text] [Related]
17. Effect of 3-5 monocyclizations of angiotensin II and 4-aminoPhe6-Ang II on AT2 receptor affinity.
Lindman S; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2003 Jul; 11(13):2947-54. PubMed ID: 12788364
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.
Roumelioti P; Polevaya L; Zoumpoulakis P; Giatas N; Mutule I; Keivish T; Zoga A; Vlahakos D; Iliodromitis E; Kremastinos D; Grdadolnik SG; Mavromoustakos T; Matsoukas J
Bioorg Med Chem Lett; 2002 Sep; 12(18):2627-33. PubMed ID: 12182875
[TBL] [Abstract][Full Text] [Related]
20. 4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists.
Norman MH; Smith HD; Andrews CW; Tang FL; Cowan CL; Steffen RP
J Med Chem; 1995 Nov; 38(23):4670-8. PubMed ID: 7473594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
